e-Article
An Indirect Comparison of the Efficacy and Safety of Dostarlimab and Doxorubicin for the Treatment of Advanced and Recurrent Endometrial Cancer
Document Type
Article
Author
Source
In: Oncologist . (Oncologist, December 2022, 27(12):1058-1066)
Subject
Language
English
ISSN
1549490X
10837159
10837159